JP2003517458A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003517458A5 JP2003517458A5 JP2000613411A JP2000613411A JP2003517458A5 JP 2003517458 A5 JP2003517458 A5 JP 2003517458A5 JP 2000613411 A JP2000613411 A JP 2000613411A JP 2000613411 A JP2000613411 A JP 2000613411A JP 2003517458 A5 JP2003517458 A5 JP 2003517458A5
- Authority
- JP
- Japan
- Prior art keywords
- groups
- term
- alkyl
- group
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 description 13
- -1 2-aminobutyl Chemical group 0.000 description 6
- 125000001931 aliphatic group Chemical group 0.000 description 6
- 125000003342 alkenyl group Chemical group 0.000 description 6
- 125000003545 alkoxy group Chemical group 0.000 description 6
- 125000002723 alicyclic group Chemical group 0.000 description 5
- 125000005157 alkyl carboxy group Chemical group 0.000 description 5
- 125000004414 alkyl thio group Chemical group 0.000 description 5
- 125000003118 aryl group Chemical group 0.000 description 5
- 125000000623 heterocyclic group Chemical group 0.000 description 5
- 0 *N1CC(CCCC2)=C2CC1 Chemical compound *N1CC(CCCC2)=C2CC1 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 125000003282 alkyl amino group Chemical group 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 229910052736 halogen Inorganic materials 0.000 description 4
- 150000002367 halogens Chemical class 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 4
- KAESVJOAVNADME-UHFFFAOYSA-N 1H-pyrrole Natural products C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 125000000304 alkynyl group Chemical group 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 150000001925 cycloalkenes Chemical class 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- ZSWFCLXCOIISFI-UHFFFAOYSA-N cyclopentadiene Chemical compound C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 125000003396 thiol group Chemical class [H]S* 0.000 description 2
- KKZUMAMOMRDVKA-UHFFFAOYSA-N 2-chloropropane Chemical group [CH2]C(C)Cl KKZUMAMOMRDVKA-UHFFFAOYSA-N 0.000 description 1
- AUFIRGPROMANKW-UHFFFAOYSA-N CN1CC=CCC1 Chemical compound CN1CC=CCC1 AUFIRGPROMANKW-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- KDUIUFJBNGTBMD-VXMYFEMYSA-N cyclooctatetraene Chemical compound C1=C\C=C/C=C\C=C1 KDUIUFJBNGTBMD-VXMYFEMYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002790 naphthalenes Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13146499P | 1999-04-28 | 1999-04-28 | |
| US60/131,464 | 1999-04-28 | ||
| US13554599P | 1999-05-24 | 1999-05-24 | |
| US60/135,545 | 1999-05-24 | ||
| US14312399P | 1999-07-09 | 1999-07-09 | |
| US60/143,123 | 1999-07-09 | ||
| PCT/CA2000/000494 WO2000064420A2 (en) | 1999-04-28 | 2000-04-28 | Compositions and methods for treating amyloidosis using sulphonate derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003517458A JP2003517458A (ja) | 2003-05-27 |
| JP2003517458A5 true JP2003517458A5 (OSRAM) | 2011-04-14 |
| JP4726304B2 JP4726304B2 (ja) | 2011-07-20 |
Family
ID=27384158
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000613411A Expired - Fee Related JP4726304B2 (ja) | 1999-04-28 | 2000-04-28 | アミロイドーシスを治療するための組成物および方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US20040198832A1 (OSRAM) |
| EP (1) | EP1276483B1 (OSRAM) |
| JP (1) | JP4726304B2 (OSRAM) |
| KR (2) | KR20070094996A (OSRAM) |
| CN (1) | CN100482233C (OSRAM) |
| AT (1) | ATE441421T1 (OSRAM) |
| AU (1) | AU4282400A (OSRAM) |
| BR (1) | BR0010099A (OSRAM) |
| CA (1) | CA2369997C (OSRAM) |
| DE (1) | DE60042896D1 (OSRAM) |
| DK (1) | DK1276483T3 (OSRAM) |
| ES (1) | ES2331905T3 (OSRAM) |
| IL (1) | IL146143A0 (OSRAM) |
| MX (1) | MXPA01010835A (OSRAM) |
| NZ (1) | NZ543319A (OSRAM) |
| WO (1) | WO2000064420A2 (OSRAM) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040208875A1 (en) * | 1995-03-15 | 2004-10-21 | Queen's University At Kingston | Method for treating amyloidosis |
| US6562836B1 (en) | 1999-05-24 | 2003-05-13 | Queen's University Of Kingston | Methods and compounds for inhibiting amyloid deposits |
| HK1051137A1 (zh) * | 1999-07-09 | 2003-07-25 | Isis Innovation Limited | 抑制疾病的化合物和製備移植用的細胞 |
| US7311893B2 (en) | 2000-07-25 | 2007-12-25 | Neurochem (International) Limited | Amyloid targeting imaging agents and uses thereof |
| US6716589B2 (en) * | 2000-11-20 | 2004-04-06 | Alphabeta Ab | Discordant helix stabilization for prevention of amyloid formation |
| EP1528920B1 (en) * | 2002-08-12 | 2013-07-24 | Yuuichi Murayama | Suppression of abnormal proliferation of prion proteins with leucine, isoleucine or valine |
| CA2511599A1 (en) * | 2002-12-24 | 2004-07-15 | Neurochem (International) Limited | Therapeutic formulations for the treatment of beta-amyloid related diseases |
| US20050142191A1 (en) * | 2003-06-23 | 2005-06-30 | Neurochem (International) Limited | Pharmaceutical formulations of amyloid inhibiting compounds |
| BRPI0411743A (pt) * | 2003-06-23 | 2006-08-08 | Neurochem Int Ltd | método e composições para tratar doenças relacionadas a amilóides |
| AU2011250847B2 (en) * | 2003-06-23 | 2013-06-20 | Bhi Limited Partnership | Methods and compositions for treating amyloid-related diseases |
| US7414076B2 (en) | 2003-06-23 | 2008-08-19 | Neurochem (International) Limited | Methods and compositions for treating amyloid-related diseases |
| US7253306B2 (en) | 2003-06-23 | 2007-08-07 | Neurochem (International) Limited | Pharmaceutical drug candidates and methods for preparation thereof |
| US7244764B2 (en) * | 2003-06-23 | 2007-07-17 | Neurochem (International) Limited | Methods and compositions for treating amyloid-related diseases |
| JP2007516940A (ja) * | 2003-06-23 | 2007-06-28 | ニューロケム （インターナショナル） リミテッド | 改善された薬剤候補およびその調製法 |
| AU2005310986A1 (en) * | 2004-11-12 | 2006-06-08 | Bellus Health (International) Limited | Methods and fluorinated compositions for treating amyloid-related diseases |
| EP1817305A2 (en) * | 2004-11-16 | 2007-08-15 | Neurochem (International) Limited | Compounds for the treatment of cns and amyloid associated diseases |
| CN101128421A (zh) * | 2004-12-22 | 2008-02-20 | 神经化学（国际）有限公司 | 治疗淀粉样相关疾病用的方法与组合物 |
| TW200716088A (en) | 2005-04-15 | 2007-05-01 | Neurochem Int Ltd | Formulations and methods for treating amyloidosis |
| FI3851447T3 (fi) | 2006-10-12 | 2023-11-15 | Bellus Health Inc | Menetelmiä, yhdisteitä, koostumuksia ja vehikkeleitä 3-amino-1-propaanisulfonihapon vapauttamiseksi |
| KR100883132B1 (ko) | 2006-10-24 | 2009-02-10 | 재단법인서울대학교산학협력재단 | 아밀로이드 형성 펩타이드 또는 단백질의 가용성 회합체에선택적으로 작용하는 절단제 |
| EP2121633A2 (en) | 2007-02-12 | 2009-11-25 | Merck & Co., Inc. | Piperazine derivatives for treatment of ad and related conditions |
| EA201100142A1 (ru) * | 2008-07-10 | 2011-10-31 | Новартис Аг | Циклические сулфоны, замещенные аминобензилом, применимые в качестве ингибиторов васе |
| ES2965867T3 (es) | 2015-08-10 | 2024-04-17 | Alzheon Inc | Composiciones y métodos para el tratamiento y la prevención de trastornos neurodegenerativos |
| MA47595A (fr) * | 2017-02-24 | 2020-01-01 | Alzheon Inc | Méthodes de traitement d'affections neurodégénératives |
| USD852236S1 (en) | 2017-08-17 | 2019-06-25 | Samsung Electronics Co., Ltd. | Refrigerator |
| US20250345298A1 (en) | 2022-04-28 | 2025-11-13 | Alzheon, Inc. | Apoe4 correctors and methods of use |
| JP2025539186A (ja) | 2022-12-02 | 2025-12-03 | アルツェオン・インコーポレーテッド | トラミプロセートを用いて神経変性障害を治療する方法 |
Family Cites Families (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2531468A (en) * | 1949-04-14 | 1950-11-28 | Eastman Kodak Co | Polyvinyl sulfonates and process for their preparation |
| DE1122064B (de) * | 1960-01-09 | 1962-01-18 | Basf Ag | Verfahren zur Einfuehrung von alyphatischen Kohlenwasserstoffresten in organische Verbindungen, die Hydroxylgruppen, tertiaere Aminogruppen, aromatische gebundene Sulfhydrylgruppen und bzw. oder aromatisch gebundene primaere oder sekundaere Aminogruppen enthalten |
| US3218352A (en) * | 1962-05-03 | 1965-11-16 | Abbott Lab | Homotaurine process |
| US3658966A (en) * | 1969-09-15 | 1972-04-25 | Kowa Co | Methods of treating hypertension |
| US3920833A (en) * | 1974-08-08 | 1975-11-18 | Stanley Drug Products Inc | Antifibrinolytic agents |
| FR2384751A1 (fr) * | 1977-03-23 | 1978-10-20 | Francaise Coop Pharma | Nouveaux derives de la taurine a activite neuro-musculaire renforcee |
| CA1144937A (en) * | 1977-12-22 | 1983-04-19 | Dke J.E. Helgstrand | Aromatic derivatives, pharmaceutical compositions and methods for combatting virus infections |
| FR2457281A1 (fr) * | 1979-05-23 | 1980-12-19 | Meram Lab | Nouveaux derives de l'acide 3-aminopropanesulfonique ayant une activite membranaire renforcee |
| US4255448A (en) * | 1979-09-10 | 1981-03-10 | Wisconsin Alumni Research Foundation | Method for reducing epileptiform activity |
| US4448779A (en) * | 1981-07-16 | 1984-05-15 | Sanofi | Use of MS salt in geriatric medicine |
| JPS5879022A (ja) * | 1981-11-04 | 1983-05-12 | Bitamin Kenkyusho:Kk | 第四級窒素原子を含有する新規な金属架橋高分子化合物、その製法及び該高分子化合物を有効成分とする高脂血症治療剤 |
| US4540564A (en) * | 1982-05-18 | 1985-09-10 | University Of Florida | Brain-specific drug delivery |
| US5087618A (en) * | 1982-05-18 | 1992-02-11 | University Of Florida | Redox carriers for brain-specific drug delivery |
| FR2529546A1 (fr) * | 1982-07-05 | 1984-01-06 | Meram Lab | Nouveaux sels d'amino-(et imino-)acides a, o-sulfoniques n-substitues, vecteurs cationiques de haute penetration cellulaire |
| US4522811A (en) * | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| DE3229300A1 (de) * | 1982-08-05 | 1984-02-09 | Haarmann & Reimer Gmbh, 3450 Holzminden | Aliphatische dicarbonsaeureester als riechstoffe und diese enthaltende parfuemkompositionen und parfuemierte produkte |
| US4737353A (en) * | 1984-04-13 | 1988-04-12 | Union Carbide Corporation | Beryllium-aluminum-phosphorus-silicon-oxide molecular sieve compositions |
| US5374548A (en) * | 1986-05-02 | 1994-12-20 | Genentech, Inc. | Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor |
| MX9203291A (es) * | 1985-06-26 | 1992-08-01 | Liposome Co Inc | Metodo para acoplamiento de liposomas. |
| JPH0786122B2 (ja) * | 1986-05-30 | 1995-09-20 | 日本ペイント株式会社 | 三次元架橋された微小樹脂粒子およびその製造法 |
| US4847082A (en) * | 1987-01-21 | 1989-07-11 | Robert Sabin | Method of treatment of Alzheimer's disease using phytic acid |
| US5166320A (en) * | 1987-04-22 | 1992-11-24 | University Of Connecticut | Carrier system and method for the introduction of genes into mammalian cells |
| IT1205042B (it) * | 1987-05-28 | 1989-03-10 | Crinos Industria Farmaco | Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer |
| US5108921A (en) * | 1989-04-03 | 1992-04-28 | Purdue Research Foundation | Method for enhanced transmembrane transport of exogenous molecules |
| US5194654A (en) * | 1989-11-22 | 1993-03-16 | Vical, Inc. | Lipid derivatives of phosphonoacids for liposomal incorporation and method of use |
| US5463092A (en) * | 1989-11-22 | 1995-10-31 | Vestar, Inc. | Lipid derivatives of phosphonacids for liposomal incorporation and method of use |
| US5385915A (en) * | 1990-05-16 | 1995-01-31 | The Rockefeller University | Treatment of amyloidosis associated with Alzheimer disease using modulators of protein phosphorylation |
| US5242932A (en) * | 1991-12-17 | 1993-09-07 | The Rockefeller University | Treatment of amyloidosis associated with alzheimer disease |
| US5668117A (en) * | 1991-02-22 | 1997-09-16 | Shapiro; Howard K. | Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments |
| US5164295A (en) * | 1991-03-06 | 1992-11-17 | The Upjohn Company | Method for identifying amyloid protein-extracellular matrix protein affinity altering compounds |
| US5192753A (en) * | 1991-04-23 | 1993-03-09 | Mcgeer Patrick L | Anti-rheumatoid arthritic drugs in the treatment of dementia |
| ES2096064T3 (es) * | 1991-12-19 | 1997-03-01 | Ciba Geigy Ag | Derivados del acido aminosulfonico y procedimiento para su obtencion. |
| US5276059A (en) * | 1992-07-10 | 1994-01-04 | The United States Of America As Represented By The Department Of Health And Human Services | Inhibition of diseases associated with amyloid formation |
| US5840294A (en) * | 1993-03-29 | 1998-11-24 | Queen's University At Kingston | Method for treating amyloidosis |
| US5643562A (en) * | 1993-03-29 | 1997-07-01 | Queen's University Of Kingston | Method for treating amyloidosis |
| US5972328A (en) * | 1993-03-29 | 1999-10-26 | Queen's University At Kingston | Method for treating amyloidosis |
| US5646562A (en) * | 1993-07-21 | 1997-07-08 | Seiko Epson Corporation | Phase synchronization circuit, one-shot pulse generating circuit and signal processing system |
| US5488145A (en) * | 1993-12-23 | 1996-01-30 | Oklahoma Medical Research Foundation | 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps |
| US5858326A (en) * | 1995-06-06 | 1999-01-12 | Neurochem, Inc. | Methods of increasing amyloid deposition |
| DE19531342B4 (de) * | 1995-08-25 | 2007-11-29 | Merz Pharma Gmbh & Co. Kgaa | Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren |
| AU703540B2 (en) * | 1996-03-26 | 1999-03-25 | Meddiss, Incorporated | Methods for inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general |
| CA2217322C (en) * | 1996-10-03 | 2005-01-04 | Coastside Bio Resources | Inhibition of complement pathway by sea cucumber fractions |
| US7078191B1 (en) * | 1997-08-01 | 2006-07-18 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation |
| WO1999008685A1 (en) * | 1997-08-18 | 1999-02-25 | Queen's University At Kingston | Phosphono-carboxylate compounds for treating amyloidosis |
| US6294583B1 (en) * | 1998-01-13 | 2001-09-25 | Synchroneuron, Llc | Methods of treating tardive dyskinesia and other movement disorders |
| EP1054664B1 (en) * | 1998-02-11 | 2012-08-08 | BHI Limited Partnership | Method for modulating macrophage activation |
| US20020022657A1 (en) * | 1998-02-11 | 2002-02-21 | Francine Gervais | Methods for modulating neuronal cell death |
| US6329356B1 (en) * | 1998-04-10 | 2001-12-11 | Neurochem, Inc. | Phosphono-carboxylate compounds for treating amyloidosis |
| US6310073B1 (en) * | 1998-07-28 | 2001-10-30 | Queen's University At Kingston | Methods and compositions to treat glycosaminoglycan-associated molecular interactions |
| US6562836B1 (en) * | 1999-05-24 | 2003-05-13 | Queen's University Of Kingston | Methods and compounds for inhibiting amyloid deposits |
| US20070135337A2 (en) * | 1999-11-29 | 2007-06-14 | Neurochem (International) Limited | Vaccine for the Prevention and Treatment of Alzheimer's and Amyloid Related Diseases |
| US6376557B1 (en) * | 2000-03-16 | 2002-04-23 | Chanda Bhuwalka Zaveri | Methods for treating alopecia |
| CA2440834A1 (en) * | 2001-03-13 | 2002-09-19 | Queen's University At Kingston | Anti-epileptogenic agents |
| KR20040036908A (ko) * | 2001-08-31 | 2004-05-03 | 뉴로겜 인터내셔널 리미티드 | 아밀로이드증 치료용 아미딘 유도체 |
| US20040096553A1 (en) * | 2002-11-20 | 2004-05-20 | James E. Lynch | Ice cream cone drip guard |
| US7253306B2 (en) * | 2003-06-23 | 2007-08-07 | Neurochem (International) Limited | Pharmaceutical drug candidates and methods for preparation thereof |
| US7244764B2 (en) * | 2003-06-23 | 2007-07-17 | Neurochem (International) Limited | Methods and compositions for treating amyloid-related diseases |
| US20050142191A1 (en) * | 2003-06-23 | 2005-06-30 | Neurochem (International) Limited | Pharmaceutical formulations of amyloid inhibiting compounds |
| US20070010573A1 (en) * | 2003-06-23 | 2007-01-11 | Xianqi Kong | Methods and compositions for treating amyloid-related diseases |
| US7262223B2 (en) * | 2004-01-23 | 2007-08-28 | Neurochem (International) Limited | Amidine derivatives for treating amyloidosis |
| US20080038192A1 (en) * | 2004-07-19 | 2008-02-14 | Neurochem Inc. | Diagnostic Methods Of Multiple Organ Amyloidosis |
| CN101128421A (zh) * | 2004-12-22 | 2008-02-20 | 神经化学（国际）有限公司 | 治疗淀粉样相关疾病用的方法与组合物 |
-
2000
- 2000-04-28 DE DE60042896T patent/DE60042896D1/de not_active Expired - Lifetime
- 2000-04-28 KR KR1020077021102A patent/KR20070094996A/ko not_active Abandoned
- 2000-04-28 AU AU42824/00A patent/AU4282400A/en not_active Abandoned
- 2000-04-28 EP EP00922395A patent/EP1276483B1/en not_active Expired - Lifetime
- 2000-04-28 BR BR0010099-4A patent/BR0010099A/pt not_active IP Right Cessation
- 2000-04-28 CN CNB008094152A patent/CN100482233C/zh not_active Expired - Fee Related
- 2000-04-28 KR KR1020017013824A patent/KR100822525B1/ko not_active Expired - Fee Related
- 2000-04-28 IL IL14614300A patent/IL146143A0/xx unknown
- 2000-04-28 AT AT00922395T patent/ATE441421T1/de not_active IP Right Cessation
- 2000-04-28 WO PCT/CA2000/000494 patent/WO2000064420A2/en not_active Ceased
- 2000-04-28 DK DK00922395T patent/DK1276483T3/da active
- 2000-04-28 CA CA002369997A patent/CA2369997C/en not_active Expired - Fee Related
- 2000-04-28 MX MXPA01010835A patent/MXPA01010835A/es active IP Right Grant
- 2000-04-28 ES ES00922395T patent/ES2331905T3/es not_active Expired - Lifetime
- 2000-04-28 JP JP2000613411A patent/JP4726304B2/ja not_active Expired - Fee Related
- 2000-04-28 NZ NZ543319A patent/NZ543319A/en not_active IP Right Cessation
-
2003
- 2003-08-11 US US10/639,609 patent/US20040198832A1/en not_active Abandoned
-
2008
- 2008-07-07 US US12/217,580 patent/US20090099100A1/en not_active Abandoned
-
2011
- 2011-04-14 US US13/066,451 patent/US20110281951A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003517458A5 (OSRAM) | ||
| WO2002003984A3 (en) | Anticonvulsant derivatives useful for treating and preventing the development of type ii diabetes mellitus and syndrome x | |
| ES405652A1 (es) | Procedimiento para el aclarado optico de materiales organi-cos. | |
| MY134664A (en) | 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipedemia | |
| WO2005033230A3 (en) | Low-cure powder coatings, related coating method and coated substrates | |
| WO2004114371A3 (de) | Verbindung zur bildung einer selbstorganisierenden monolage, schichtstruktur, halbleiterbauelement mit einer schichtstruktur und verfahren zur herstellung einer schichtstruktur | |
| EP1284266A4 (en) | NEW INDOIND DERIVATIVES WITH CHYME-INHIBITABLE ACTIVITIES AND METHOD FOR THEIR PREPARATION | |
| WO2003059900A1 (en) | Coumarin derivatives, process for their production and use thereof | |
| CA2113603A1 (en) | Tricyclic condensed heterocyclic compounds, their production and use | |
| WO1999009965A3 (en) | Anti-inflammatory agent | |
| WO2003059907A1 (en) | Nitrogenous heterocyclic compounds, process for preparation of the same and use thereof | |
| WO2001035947A3 (en) | Treating wasting syndromes with aryloxy propanolamines | |
| EP1506777A4 (en) | MEANS FOR PREVENTING OR REDUCING FAT SUPPORT WITH A METHYLIDENHYDRAZIDE COMPOUND AS AN ACTIVE SUBSTANCE | |
| BG104034A (en) | Method for the preparation of pharmaceutical compounds of antidepressive effect and against the parkinson syndrome effect | |
| BR9405608A (pt) | Processo para preparaçào de polìmeros contendo lignina | |
| Chen et al. | Synthesis and bioactivity evaluation of 3‐hydroxy‐3‐(phenylethynyl) indol‐2‐one analogues | |
| DE60228053D1 (de) | Benzamidinderivate mit entzündungshemmender und immunsuppressiver wirkung | |
| MX173689B (es) | Procedimiento para la fabricacion de multicapas de polimida gruesas | |
| ES454165A1 (es) | Un procedimiento para la preparacion de 3',4'-didesiva en superficie de poliester. | |
| EP1403253A4 (en) | NEW HETEROCYCLIC CONNECTION AND THEIR MEDICAL USE | |
| JPS5473900A (en) | Curable resin composition | |
| IE38821B1 (en) | Thiophene derivatives process for their preparation and compositions incorporating them | |
| EP1273587A4 (en) | METHOD FOR PRODUCING A 3-VINYL CEPHEM COMPOUND | |
| EP0919556A4 (en) | METHOD FOR PRODUCING HEXANITROHEXAAZAWURTZITANEEN | |
| KR950010897A (ko) | 신규의 화학적 보호제(chemopreventive agent) 및 그의 제조방법 |